Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06124456 Sponsor: The University of Hong Kong Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT06124456
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who speak Cantonese, Mandarin, or English and are of Chinese background
  • People aged between 18 and 69 years old
  • People who have a larger-than-recommended waist size (90 cm or more for men, 80 cm or more for women) and a body mass index (BMI) of 23 or higher, which is considered overweight by Hong Kong government standards
  • People who have been diagnosed with a liver condition called NAFLD (non-alcoholic fatty liver disease), where more than 5% of the liver contains fat, confirmed by a specific type of scan called MR spectroscopy
  • People who are physically able to take part in the exercise program required by the trial

Who may not be able to join:

  • People who have been doing regular exercise (more than 3 sessions per week, each longer than 60 minutes, at moderate intensity) in the past 6 months
  • People with a history of heart disease, long-term lung or kidney disease, heart failure, cancer, or any liver disease other than NAFLD
  • People with a physical condition that prevents them from exercising, such as loss of a limb
  • People whose ability to move around is limited by a long-term condition, such as severe arthritis, a neurological condition, a muscle or bone condition, or an autoimmune disease
  • People who smoke daily
  • People who have drunk more than a certain amount of alcohol every day in the past year (20 grams or more per day for men, 10 grams or more per day for women)
  • People who are taking certain medications — such as tamoxifen or estrogen — that are known to cause fat to build up in the liver
  • People who have had weight-loss surgery or a dietitian-supervised diet program in the past 6 months, or who are currently undergoing one (for example, gastric bypass, gastric sleeve, or gastric band surgery)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Parco M Siu, PhD, LKS Faculty of Medicine, The University of Hong Kong

Phone: 28315262

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 May 2024
Est. completion
1 October 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Liver Fat

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov